Webinar – Clinical consequences of the New MASLD Nomenclature
On the 27th of June, we organized the webinar: ‘Clinical Consequences of the New MASLD Nomenclature‘ with guest speaker Prof. Maja Thiele.
During this webinar, our speaker and hosts dived into the following topics:
- Is the MASLD nomeclature of prognostic relevance?
- Do we need to re-validate all NILTs after the new nomenclature?
- Considerations for “the new kid in town”: MetALD
Speakers, hosts, and audience
- Speaker: Prof. Maja Thiele
- Hosts: Prof. Manuel Castro Cabezas & Prof. Christophe Moreno
- Audience: Clinicians, researchers, pharmaceutical industry workers, public health workers
You can watch the replay here: https://vimeo.com/973037860
Related webinars
Webinar – Improving ALS Trial Delivery Through Insights from Patient and Industry Experience
On January 19, at 16.30 CET, we will present the webinar: Improving ALS Trial Delivery Through Insights from Patient and Industry ExperienceWhat You’ll LearnPatient- and Industry-Informed Insights Top patient-experience pitfalls obs...
Webinar – Boosting patient enrolment and retention in clinical trials: Expert Insights & Tips
On June 30, at 16.00 CEST, we will present the webinar: Boosting patient enrolment and retention in clinical trials: Expert Insights & TipsJoin us for an interactive discussion with experts who will draw upon recent cardiology and neurolog...
Webinar – The role of EEG in dementia trials
On May 6th, 2025, we will organised the webinar: The role of EEG in dementia trials During this webinar, our speakers Pieter van Mierlo, Dr. Willem de Haan and host Lieza Exalto will explore the following topics:Practical aspects and resti...
